​

NeuroOne Medical (NMTC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NMTC Stock Forecast

NeuroOne Medical (NMTC) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 284.62% increase from the last price of $1.30.

- $1 $2 $3 $4 $5 High: $5 Avg: $5 Low: $5 Last Closed Price: $1.3

NMTC Stock Rating

NeuroOne Medical stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

NMTC Price Target Upside V Benchmarks

TypeNameUpside
StockNeuroOne Medical284.62%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks23.18%

Price Target Trends

1M3M12M
# Anlaysts-11
Avg Price Target-$5.00$5.00
Last Closing Price$1.30$1.30$1.30
Upside/Downside-284.62%284.62%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 2612---3
Aug, 2612---3
Jul, 2612---3
Jun, 2612---3
May, 2612---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 14, 2026Maxim Group$5.00$1.81176.24%284.62%
Sep 09, 2025Maxim Group$3.00$0.89237.08%130.77%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change

Financial Forecast

EPS Forecast

Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26
Reported$-0.93$-0.63$-0.65$-0.46$-0.09-
Avg Forecast$-1.05$-0.65$-0.70$-0.41$-0.31$-0.18
High Forecast$-1.05$-0.65$-0.70$-0.41$-0.31$-0.18
Low Forecast$-1.05$-0.65$-0.70$-0.41$-0.31$-0.18
Surprise %-11.43%-3.08%-7.14%12.20%-70.97%-

Revenue Forecast

$0 $4M $8M $12M $16M $20M Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26
Reported$178.15K$171.17K$1.95M$3.45M$9.10M-
Avg Forecast$200.00K$1.90M$3.50M$5.50M$10.20M$15.20M
High Forecast$200.00K$1.90M$3.50M$5.50M$10.20M$15.20M
Low Forecast$200.00K$1.90M$3.50M$5.50M$10.20M$15.20M
Surprise %-10.93%-90.99%-44.22%-37.22%-10.81%-

Net Income Forecast

$-20M $-16M $-12M $-8M $-4M $0 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26
Reported$-9.95M$-10.00M$-11.86M$-12.32M$-3.61M-
Avg Forecast$-18.94M$-11.78M$-18.60M$-10.97M$-8.30M$-4.82M
High Forecast$-18.94M$-11.78M$-18.60M$-10.97M$-8.30M$-4.82M
Low Forecast$-18.94M$-11.78M$-18.60M$-10.97M$-8.30M$-4.82M
Surprise %-47.47%-15.10%-36.24%12.26%-56.54%-

NMTC Forecast FAQ

Is NeuroOne Medical stock a buy?

NeuroOne Medical stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that NeuroOne Medical is a favorable investment for most analysts.

What is NeuroOne Medical's price target?

NeuroOne Medical's price target, set by 4 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 284.62% change from the previous closing price of $1.3.

How does NeuroOne Medical stock forecast compare to its benchmarks?

NeuroOne Medical's stock forecast shows a 284.62% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (23.18%).

What is the breakdown of analyst ratings for NeuroOne Medical over the past three months?

  • September 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • July 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is NeuroOne Medical’s EPS forecast?

NeuroOne Medical's average annual EPS forecast for its fiscal year ending in September 2026 is $-0.18, marking a 100.00% increase from the reported $-0.09 in 2025..

What is NeuroOne Medical’s revenue forecast?

NeuroOne Medical's average annual revenue forecast for its fiscal year ending in September 2026 is $15.2M, reflecting a 67.08% increase from the reported $9.1M in 2025.

What is NeuroOne Medical’s net income forecast?

NeuroOne Medical's net income forecast for the fiscal year ending in September 2026 stands at $-4.817M, representing an 33.61% increase from the reported $-3.605M in 2025.